Life sciences industry outlook

Jul 24, 2020

Despite the recession, there are signs of strength for life sciences in both public markets and private investment.

Posted by RSM

Key takeaways from the Summer 2020 Life Sciences Industry Outlook:

  • Despite the recession, there are signs of strength for life sciences in both public markets and private investment.
  • The pandemic has pushed companies to reallocate resources toward COVID-19, causing disruption to the clinical trial pipeline.
  • The hot topics of health care and drug pricing reform have taken a backseat as the country deals with the fallout of the pandemic and recession.

Read more at https://rsmus.com/what-we-do/industries/life-sciences/industry-outlook-life-sciences.html 

Download Attachment

See all Member News